Haemonetics Newsroom

Haemonetics Initiated at Buy by CL King

Dow JonesSep 14 03:45

Haemonetics Analyst Ratings

BenzingaSep 14 03:35

C.L. King Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $116

Futu NewsSep 13 21:32

BofA Securities Initiates Haemonetics(HAE.US) With Hold Rating, Announces Target Price $85

Futu NewsSep 11 19:33

Haemonetics Price Target Announced at $85.00/Share by B of A Securities

Dow JonesSep 11 19:20

BTIG Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $112

Futu NewsSep 10 18:31

Haemonetics Analyst Ratings

BenzingaAug 22 23:45

Citi Maintains Haemonetics(HAE.US) With Hold Rating, Cuts Target Price to $85

Futu NewsAug 22 18:33

Haemonetics Analyst Ratings

BenzingaAug 14 02:42

JMP Securities Reiterates Market Outperform on Haemonetics, Maintains $125 Price Target

BenzingaAug 14 02:42

Haemonetics Corporation: Strong Growth and Innovation Justify a Buy Rating

TipRanksAug 13 03:49

Haemonetics Analyst Ratings

BenzingaAug 10 05:47

Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $108

BenzingaAug 10 05:46

Haemonetics: A Stable Outlook With Promising Profitability Targets Justifies Buy Rating

TipRanksAug 9 00:18

Haemonetics Analyst Ratings

BenzingaJun 12 17:30

Haemonetics Positioned for Strong Growth: Buy Rating Justified Amidst Operational and Financial Optimism

TipRanksMay 14 17:15

Haemonetics Analyst Ratings

BenzingaMay 11 00:55

Barrington Research: Maintaining the Haemonetics (HAE.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $105.00 to $107.00.

Zhitong FinanceMay 10 22:32

Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $107

BenzingaMay 10 22:30

Haemonetics Analyst Ratings

BenzingaMay 10 17:55